Results 161 to 170 of about 20,794 (210)
Health-related quality of life in adults with von Willebrand disease: results of the French real-life Willebrand study on health-related quality of life. [PDF]
Borel-Derlon A +15 more
europepmc +1 more source
Correction to "Extension Study With rVIII-SingleChain in Previously Untreated Patients (PUPs) With Severe Hemophilia A". [PDF]
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nature Reviews Disease Primers, 2021
Haemophilia A and B are rare congenital, recessive X-linked disorders caused by lack or deficiency of clotting factor VIII (FVIII) or IX (FIX), respectively. The severity of the disease depends on the reduction of levels of FVIII or FIX, which are determined by the type of the causative mutation in the genes encoding the factors (F8 and F9 ...
Erik Berntorp +2 more
exaly +5 more sources
Haemophilia A and B are rare congenital, recessive X-linked disorders caused by lack or deficiency of clotting factor VIII (FVIII) or IX (FIX), respectively. The severity of the disease depends on the reduction of levels of FVIII or FIX, which are determined by the type of the causative mutation in the genes encoding the factors (F8 and F9 ...
Erik Berntorp +2 more
exaly +5 more sources
Lancet, The
Haemophilia A and B are congenital X-linked bleeding disorders resulting from deficiencies in clotting factors VIII (haemophilia A) and IX (haemophilia B). Patients with severe deficiency, defined as having less than 1% of normal plasma factor activivity, often have spontaneous bleeding within the first few years of life.
Pratima, Chowdary +3 more
exaly +5 more sources
Haemophilia A and B are congenital X-linked bleeding disorders resulting from deficiencies in clotting factors VIII (haemophilia A) and IX (haemophilia B). Patients with severe deficiency, defined as having less than 1% of normal plasma factor activivity, often have spontaneous bleeding within the first few years of life.
Pratima, Chowdary +3 more
exaly +5 more sources
British Journal of Perioperative Nursing (United Kingdom), 2004
This is the third article in a series that aims to refresh readers’ knowledge of blood. This article describes haemophilia which is a congenital disorder of coagulation. Vicky Vidler describes the aetiology of Haemophilia A and B, their clinical manifestations and the treatment options available to manage these patients in the perioperative period.
Vicky Vidler, Falicia Cox
+7 more sources
This is the third article in a series that aims to refresh readers’ knowledge of blood. This article describes haemophilia which is a congenital disorder of coagulation. Vicky Vidler describes the aetiology of Haemophilia A and B, their clinical manifestations and the treatment options available to manage these patients in the perioperative period.
Vicky Vidler, Falicia Cox
+7 more sources
Expert Opinion on Biological Therapy, 2007
In the last few decades dramatic improvements in the management of haemophilia patients have occurred. Haemophilia has moved from a fatal or disabling disease to a hereditary disorder with available treatment and much better clinical outcomes. The safety of antihaemophilic factor concentrates has been dramatically improved and, in a multidisciplinary ...
Yesim, Dargaud, Claude, Negrier
openaire +2 more sources
In the last few decades dramatic improvements in the management of haemophilia patients have occurred. Haemophilia has moved from a fatal or disabling disease to a hereditary disorder with available treatment and much better clinical outcomes. The safety of antihaemophilic factor concentrates has been dramatically improved and, in a multidisciplinary ...
Yesim, Dargaud, Claude, Negrier
openaire +2 more sources
Managing Haemophilia for Life: 4th Haemophilia Global Summit
Haemophilia, 2014SummaryThe 4th Haemophilia Global Summit was held in Potsdam, Germany, in September 2013 and brought together an international faculty of haemophilia experts and delegates from multidisciplinary backgrounds. The programme was designed by an independent Scientific Steering Committee of haemophilia experts and explored global perspectives in haemophilia ...
Astermark J. +8 more
openaire +3 more sources

